AG
UTHR icon

AIA Group’s United Therapeutics UTHR Stock Holding History

AIA Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Sell
1,087
-1,328
-55% -$748K 0.01% 279
2026
Q1 		$1.43M Buy
2,415
+417
+21% +$208K 0.02% 236
2025
Q4 		$974K Buy
1,998
+699
+54% +$326K 0.01% 254
2025
Q3 		$545K Buy
+1,299
New +$437K 0.01% 337
2025
Q1 		– Sell
-608
Closed -$215K – 339
2024
Q4 		$215K Buy
+608
New +$223K 0.01% 293
2023
Q2 		– Sell
-4,000
Closed -$896K – 494
2023
Q1 		$896K Buy
+4,000
New +$986K 0.05% 166
2021
Q1 		– Sell
-4,000
Closed -$680K – 211
2020
Q4 		$680K Buy
+4,000
New +$525K 0.08% 101

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

AIA Group's UTHR Position: Q2 2026 in Review

AIA Group reduced its United Therapeutics (UTHR) stake by 55% in Q2 2026, selling an estimated $748K and leaving 1,087 shares worth $589K. The position accounts for 0.01% of the portfolio, ranked #279.

AIA Group first reported a position in UTHR in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.43M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • AIA Group held 1,087 shares of United Therapeutics worth $589K as of Q2 2026.
  • AIA Group sold 1,328 United Therapeutics shares in Q2 2026, an estimated $748K.
  • United Therapeutics made up 0.01% of AIA Group's portfolio in Q2 2026, its #279 holding.
  • AIA Group first reported a position in United Therapeutics in Q4 2020 and has held it in 7 quarters since.
  • AIA Group's United Therapeutics position peaked at $1.43M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on AIA Group's 13F filing for Q2 2026, filed 31 Jul 2026.